Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials.

by Xiaoyin Wang, Lourdes I Chacon, Ronak Derakhshandeh, Hilda J Rodriguez, Daniel D Han, Dmitry S Kostyushev, Timothy D Henry, Jay H Traverse, Lem Moyé, Robert D Simari, Doris A Taylor, Matthew L Springer
Published 2020-01-01